Eczema Foundation triển khai nhiều hoạt động nhằm phát triển mối quan hệ cộng tác với các chuyên gia y tế trong lĩnh vực nghiên cứu lẫn giáo dục điều trị. Quỹ cộng tác với nhiều trung tâm giáo dục điều trị tại Pháp cũng như trên thế giới, để phát triển các chương trình đào tạo liên tục cũng như các công cụ hỗ trợ giáo dục điều trị.
The role of intestinal dysbiosis is becoming clearer / Atopic dermatitis and cardiovascular risk / The parents are trustworthy...
The 9th edition of the symposium will be held in São Paulo, Brazil, and will be sponsored by the International Society of Atopic Dermatitis (ISAD), the Brazilian Atopic Dermatitis Association (AADA) and the Department of Dermatology of the University of São Paulo Medical School. Registration is by application only.
The fear of using topical corticosteroids, usually called topical corticophobia, is a frequent concern for atopic dermatitis patients and/or their parents. Assessing patients’ atopic dermatitis and their parents’ topical corticosteroid phobia is an essential step to improving adherence to treatment. Because topical corticophobia appears to be a complex phenomenon, its evaluation by binary responses (yes/no) is too simplistic. Thus, a scale is needed, which is capable of identifying the subtleties of topical corticosteroid phobia.
The Leuven Itch Scale (LIS). The LIS is an instrument to measure itch in patients experiencing pruritus of different origin. The novelty of the LIS, in contrast with several previously developed instruments, is that it approaches itch as a symptom, and that it consequently measures all aspects of that symptom: frequency, duration, severity, circumstances, treatment, consequences, sensory characteristics, distress and location(s).
